Company research / ARQT
Arcutis Biotherapeutics, Inc. (ARQT)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, Arcutis Biotherapeutics, Inc. reported revenue of $372.07M. Revenue grew 123.4% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $461.98M.
Key ratios (year ended 2025-12-31)
90.1%
Gross margin (computed)
-3.3%
Operating margin
-4.3%
Net margin
-8.5%
Return on year-end equity
123.4%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.